Cure News: Week 7/10
Two new tidbits for you:
1. Joshua Levy takes a deeper dive on several Artificial Pancreas projects, comparing and contrasting the progress made between them.
2. There’s been a lot of talk of re-programming liver cells to produce insulin, and this week Orgenesis signed an agreement with MaSTherCell in order to scale up liver cell production for phase 2 clinical trials. This is a good sign for how promising this path may be if a larger company is willing to help with production. Stayed tuned.
Until Next Time
Thoughts? Comments? Think we missed something? Please list any comments below!
(Special Thanks to Brian Braxton This Week)